Answer
Exfoliative dermatitis, Stevens-Johnson’s syndrome, toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms (DRESS), which can be life-threatening or fatal, have been reported post-marketing with naproxen, a component of Suvexx.
Sources for this answer
- Suvexx 85 mg/457 mg film-coated tabletsOrion Pharma (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked